Parathyroid and thyroid lesions appear morphologically similar in cytological smears, and their differentiation can be difficult. The purpose of this study was to determine the diagnostic value of T-cell-specific transcription factor GATA-3 as a marker of parathyroid differentiation in cytology specimens, and to examine the utility of liquid-based cytology (LBC). Cytology smears obtained from surgically removed parathyroid and thyroid specimens, including 15 normal parathyroid glands, 12 cases of parathyroid hyperplasia, 55 parathyroid adenomas, 2 follicular thyroid adenomas, and 3 papillary thyroid carcinomas, were examined by immunocytochemistry using antibodies against GATA-3, parathyroid hormone (PTH), chromogranin A, and thyroid transcription factor 1 (TTF-1). All normal and hyperplastic parathyroids and 98.2% of parathyroid adenomas were positive for GATA-3, while 33.3%, 66.7%, and 60.0% of them, respectively, were positive for PTH. The positive rates for chromogranin A among normal parathyroids (80.0%) and parathyroid adenomas (87.3%) were lower than those for GATA-3. At the same time, all thyroid-derived tumours were positive for TTF-1 and negative for GATA-3, PTH, and chromogranin A. LBC smears of 35 parathyroid lesions indicated that the positive rates for GATA-3, PTH, and chromogranin A were 97.1 %, 97.1%, and 100%, respectively, while in conventional smears, those for PTH (25.5%) and chromogranin A (78.7%) were significantly lower (p < 0.01). Our results suggest that GATA-3 is a more reliable biomarker than PTH or chromogranin A in differentiating parathyroid from thyroid lesions in cytology smears and that LBC is useful in detecting cytoplasmic antigens such as PTH and chromogranin A.

Download full-text PDF

Source
http://dx.doi.org/10.1507/endocrj.EJ15-0700DOI Listing

Publication Analysis

Top Keywords

pth chromogranin
20
parathyroid
12
parathyroid thyroid
12
parathyroid adenomas
12
thyroid lesions
8
transcription factor
8
cytology smears
8
positive rates
8
gata-3 pth
8
gata-3
7

Similar Publications

Heterodisomy in the locus is also a cause of pseudohypoparathyroidism type 1B (iPPSD3).

Front Endocrinol (Lausanne)

December 2024

Rare Disease Research Group, Molecular (Epi) Genetics Laboratory, Bioaraba Health Research Institute, Araba University Hospital, Vitoria-Gasteiz, Spain.

Objective: To identify the genetic cause underlying the methylation defect in a patient with clinical suspicion of PHP1B/iPPSD3.

Design: Imprinting is an epigenetic mechanism that allows the regulation of gene expression. The locus is one of the loci within the genome that is imprinted.

View Article and Find Full Text PDF
Article Synopsis
  • Pseudohypoparathyroidism (PHP) is a group of disorders causing low calcium and high phosphate levels due to the body's resistance to parathyroid hormone, with PHP type 1B (PHP1B) linked to genetic deletions or methylation issues.
  • A 39-year-old male patient with PHP1B experienced his first seizure at 15, and genetic tests revealed significant abnormalities in STX16 and GNAS.
  • The study emphasizes the importance of recognizing symptoms, conducting necessary tests, and understanding genetic factors for early diagnosis and treatment of PHP1B.
View Article and Find Full Text PDF
Article Synopsis
  • Pseudohypoparathyroidism (PHP) is caused by mutations in the GNAS gene, leading to PTH resistance, with various clinical features including hormone resistance and traits from Albright hereditary osteodystrophy.
  • The study presents three sisters with the same GNAS mutation but showing significant differences in clinical presentation and biochemical changes over time.
  • Findings emphasize the importance of identifying the mutation for accurate diagnosis and the need for comprehensive patient care due to the varied manifestation of PHP1A.
View Article and Find Full Text PDF

Objectives: Pseudohypoparathyroidism type 1A (PHP1A) encompasses the association of resistance to multiple hormones, features of Albright hereditary osteodystrophy and decreased Gsα activity. Little is known about the early signs of PHP1A, with a delay in diagnosis. We report two PHP1A cases and their clinical and biochemical findings during a 20-year follow-up.

View Article and Find Full Text PDF

Background: Recognizing the parathyroid gland and distinguishing the parathyroid from thyroid lesions in fine needle aspiration (FNA) is challenging. This study aimed to identify cytomorphologic features suggestive of parathyroid origin and to assess the utility of cytopathology in conjunction with ancillary tests in the identification of parathyroid glands.

Materials And Methods: Ultrasound (US) guided FNA of parathyroid gland and lesions in 81 patients were reviewed concerning clinical history and correlated to histopathologic findings in available cases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!